查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753860

2034 年神经毒素全球市场机会与策略

Neurotoxin Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 320 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2019 年全球神经毒素市场价值为 52.9089 亿美元，到 2024 年年复合成长率(CAGR)将超过 6.00%。

神经系统疾病盛行率不断上升

神经系统疾病盛行率的上升推动了业绩期内神经毒素市场的成长。神经病变是一种影响大脑、脊髓和神经的疾病，会导致各种身体、认知和行为障碍。由于人口老化、糖尿病等慢性疾病的增加、污染等环境因素以及新冠肺炎等感染疾病的长期影响，全球神经病变呈上升趋势。神经毒素治疗透过选择性标靶和阻断异常神经活动来治疗神经病变，为慢性偏头痛、痉挛和某些运动障碍等疾病提供治疗缓解，从而改善肌肉控制并减轻症状。例如，根据美国非营利组织美国脑基金会 (美国 Brain Foundation) 的数据，2024 年 7 月，神经系统疾病将在 2021 年导致 1,110 万人死亡，影响 34 亿人，占世界人口的 43.1%。此外，根据比利时非营利组织欧洲脑理事会的数据，截至2022年4月，全球数百万人患有600多种神经系统疾病和近300种精神疾病。因此，神经系统疾病盛行率的上升正在推动神经毒素市场的成长。

目录

第一章执行摘要

  • 神经毒素－市场吸引力和宏观经济条件

第 2 章目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 神经毒素市场定义与细分
  • 按产品类型细分市场
    • 肉毒桿菌
    • Dysport
    • Xeomin
    • 其他产品
  • 按应用程式细分市场
    • 治疗
    • 美学的
    • 其他用途
  • 市场区隔：按最终用户
    • 医院
    • 专科诊所
    • 皮肤科诊所
    • 其他最终用户

第七章：主要市场趋势

  • 扩大治疗和美容用途的监管核准
  • 关注新产品发布
  • 创新优势和扩展应用
  • 市场公司之间的策略伙伴关係和合作
  • 创新神经毒素的开发

第八章全球神经毒素成长分析与策略分析框架

  • 全球神经毒性PESTEL分析（政治、社会、技术、环境与法律因素）
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 环境
    • 合法地
  • 最终用户产业（B2B）分析
    • 医院
    • 专科诊所
    • 皮肤科诊所
    • 其他最终用户
  • 全球神经毒素市场：成长率分析
  • 2019-2024年市场成长表现
    • 2019-2024年市场驱动因素
    • 2019-2024年市场限制
  • 2024-2029年、2034年市场成长预测
  • 影响成长预测的因素
    • 量化成长的贡献者
    • 驱动程式
    • 限制因素
  • 神经毒素的全球总目标市场（TAM）

9. 全球神经毒素市场区隔

  • 全球神经毒素市场（按产品类型、性能和预测），2019-2024 年、2029 年、2034 年
  • 全球神经毒素市场的应用、性能和预测（2019-2024、2029、2034）
  • 全球神经毒素市场（按最终用户、绩效及预测），2019-2024 年、2029 年、2034 年
  • 全球神经毒素市场，依肉毒桿菌型细分，绩效及预测，2019-2024、2029、2034
  • 全球神经毒素市场、 Dysport细分市场、按类型、绩效及预测（2019-2024、2029、2034）
  • 全球神经毒素市场，依Xeomin类型细分，绩效及预测，2019-2024 年、2029 年、2034 年
  • 全球神经毒素市场及其他，依类型细分，绩效及预测，2019-2024、2029、2034

第 10 章神经毒素市场：区域与国家分析

  • 全球神经毒素市场：按地区、绩效及预测，2019-2024、2029、2034
  • 全球神经毒素市场（按国家/地区划分）、绩效及预测（2019-2024 年、2029 年及 2034 年）

第十一章 亚太市场

第十二章 西欧市场

第十三章 东欧市场

第十四章 北美市场

第十五章 南美洲市场

第十六章 中东市场

第十七章：非洲市场

第十八章 竞争格局及公司概况

  • 公司简介
  • Abbvie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Ipsen Pharma SA
  • Evolus Inc.
  • Revance Therapeutics Inc.

第十九章 其他大型创新企业

  • Daewoong Pharmaceutical Co. Ltd.
  • Galderma SA
  • Sinclair Pharma plc
  • Croma-Pharma GmbH
  • Supernus Pharmaceuticals Inc.
  • Alphaeon Corporation
  • Hugel Inc.
  • Entod Pharmaceuticals Ltd.
  • Aquavit Pharmaceuticals Inc.
  • Object Pharma Inc.
  • Biotium Inc.
  • Vida Aesthetics Ltd.
  • Medytox Inc.
  • Gufic Biosciences Ltd.
  • AEON Biopharma

第20章 竞争基准化分析

第 21 章 竞争仪錶板

第22章 重大併购

  • Crown Laboratories Acquired Revance Therapeutics
  • Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

第23章神经毒素市场的最新趋势

第24章机会与策略

  • 2029年全球神经毒素市场：提供新机会的国家
  • 2029年全球神经毒素市场：细分市场带来新机会
  • 2029年全球神经毒素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 25 章神经毒素市场：结论与建议

  • 结论
  • 建议
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第26章 附录

简介目录
Product Code: o&s1673

Neurotoxins refer to a class of biological or synthetic substances that adversely affect the structure or function of the nervous system by disrupting neural transmission, damaging nerve cells, or altering neurotransmitter activity.

The neurotoxin market consists of sales, by entities (organizations, sole traders or partnerships), of neurotoxin naturally derived, such as botulinum toxin from clostridium botulinum, or synthetically engineered for therapeutic applications. While certain neurotoxins pose environmental and biological hazards, others are used in controlled doses for medical and cosmetic purposes. In healthcare, purified neurotoxins are primarily used to treat a range of neuromuscular and neurological disorders, including chronic migraine, cervical dystonia, spasticity and hyperhidrosis, as well as for aesthetic treatments to reduce facial wrinkles.

The global neurotoxin market was valued at $5,290.89 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 6.00%.

Rising Prevalence Of Neurological Disorders

The rising prevalence of neurological disorders drove the growth of the neurotoxin market during historic period. Neurological disorders are medical conditions that affect the brain, spinal cord, or nerves, leading to a range of physical, cognitive, or behavioral impairments. Neurological disorders are increasing globally due to aging populations, rising chronic diseases like diabetes, environmental factors such as pollution and the long-term effects of infections like COVID-19. Neurotoxin treatments help neurological disorders by selectively targeting and blocking abnormal nerve activity, providing therapeutic relief for conditions such as chronic migraines, spasticity and certain movement disorders, thereby improving muscle control and reducing symptoms. For instance, in July 2024, according to the American Brain Foundation, a US-based non-profit organization, in 2021, neurological disorders accounted for 11.1 million fatalities and impacted 3.4 billion people, or 43.1% of the world's population. Moreover, in April 2022, according to the European Brain Council, a Belgium-based non-profit organization, over 600 neurological diseases and nearly 300 psychiatric conditions afflict millions globally. Therefore, the rising prevalence of neurological disorders is driving the growth of the neurotoxin market.

Focus On Launch Of New Products

Major companies operating in the neurotoxin market are focusing on launching new products to strengthen their market presence. Product launch is the introduction of a new product or service into the marketplace, accompanied by a series of strategic marketing, distribution, and sales activities aimed at generating awareness, interest, and initial adoption. For example, in September 2024, Allergan Aesthetics, an AbbVie company, launched BOTOX Cosmetic (onabotulinumtoxinA) in China for the treatment of masseter muscle prominence (MMP) in adults. This approval by the China National Medical Product Administration (NMPA) makes BOTOX(R) Cosmetic the first neurotoxin approved in China for this indication. MMP is characterized by an enlarged masseter muscle, leading to a wider, square-shaped lower face, which can be an aesthetic concern for some individuals. The condition may result from genetic factors or activities such as excessive chewing or teeth grinding. Clinical trials demonstrated that treatment with BOTOX(R) Cosmetic resulted in an average reduction of facial width by 5.2mm compared to placebo, with effects typically lasting between six to nine months.

The global neurotoxin markets are highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 68.52% of the total market in 2024.

Neurotoxin Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurotoxin market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurotoxin? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurotoxin market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by application and by end user.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the unmanned underwater vehicles market.
  • Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for neurotoxin market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product Type: Botox; Dysport; Xeomin; Other products
  • 2) By Application: Therapeutic; Aesthetic; Other Applications
  • 3) By End-User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
  • Companies Mentioned: Abbvie Inc.; Merz Pharma GmbH & Co. KGaA; Ipsen Pharma SA; Evolus Inc.; Revance Therapeutics Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurotoxin indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Neurotoxin - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Neurotoxin Market Definition And Segmentations
  • 6.4 Market Segmentation By Product Type
    • 6.4.1 Botox
    • 6.4.2 Dysport
    • 6.4.3 Xeomin
    • 6.4.4 Other Products
  • 6.5 Market Segmentation By Application
    • 6.5.1 Therapeutic
    • 6.5.2 Aesthetic
    • 6.5.3 Other Applications
  • 6.6 Market Segmentation By End User
    • 6.6.1 Hospitals
    • 6.6.2 Specialty Clinics
    • 6.6.3 Dermatology Clinics
    • 6.6.4 Other End Users

7 Major Market Trends

  • 7.1 Regulatory Approvals For Expansion Of Therapeutic And Aesthetic Applications
  • 7.2 Focus On Launch Of New Products
  • 7.3 Innovating Efficacy And Expanding Applications
  • 7.4 Strategic Partnerships And Collaborations Among Market Players
  • 7.5 Innovative Neurotoxin Developments

8 Global Neurotoxin Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User Industries (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Specialty Clinics
    • 8.2.3 Dermatology Clinics
    • 8.2.4 Other End Users
  • 8.3 Global Neurotoxin Market Growth Rate Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Neurotoxin Total Addressable Market (TAM)

9 Global Neurotoxin Market Segmentation

  • 9.1 Global Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Neurotoxin Market, Sub-Segmentation By Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Neurotoxin Market, Regional and Country Analysis

  • 10.1 Global Neurotoxin Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Neurotoxin Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Neurotoxin Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Investments
    • 11.9.11 Major Companies
  • 11.10 China Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Investments
    • 11.19.11 Major Companies
  • 11.20 Japan Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 South Korea Market
  • 11.24 Summary
  • 11.25 Market Overview
    • 11.25.1 Country Information
    • 11.25.2 Market Information
    • 11.25.3 Background Information
    • 11.25.4 Government Initiatives
    • 11.25.5 Regulations
    • 11.25.6 Regulatory Bodies
    • 11.25.7 Major Associations
    • 11.25.8 Taxes Levied
    • 11.25.9 Corporate Tax Structure
    • 11.25.10 Investments
    • 11.25.11 Major Companies
  • 11.26 South Korea Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 South Korea Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 South Korea Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Australia Market
  • 11.30 Australia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 Australia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.32 Australia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.33 Indonesia Market
  • 11.34 Indonesia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 Indonesia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 Indonesia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Neurotoxin Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major Companies
  • 13.3 Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Russia Market
  • 13.7 Russia Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.8 Russia Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Neurotoxin Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulation
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 Brazil Market
  • 15.7 Brazil Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.8 Brazil Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Neurotoxin Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Neurotoxin Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Neurotoxin Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Abbvie Inc.
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Merz Pharma GmbH & Co. KGaA
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Financial Overview
  • 18.4 Ipsen Pharma SA
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Evolus Inc.
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Revance Therapeutics Inc.
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Daewoong Pharmaceutical Co. Ltd.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Galderma S.A.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Sinclair Pharma plc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Croma-Pharma GmbH
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Supernus Pharmaceuticals Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Alphaeon Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Hugel Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Entod Pharmaceuticals Ltd.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Aquavit Pharmaceuticals Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Object Pharma Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Biotium Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Vida Aesthetics Ltd.
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Medytox Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Gufic Biosciences Ltd.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 AEON Biopharma
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Crown Laboratories Acquired Revance Therapeutics
  • 22.2 Priveterra Acquisition Corp. Acquired AEON Biopharma Inc.

23 Recent Developments In The Neurotoxin Market

  • 23.1 Daewoong Pharmaceutical Introduces NABOTA To Saudi Arabia's Expanding Aesthetic Market
  • 23.2 Oxapharma Launches Clodew As A Breakthrough Toxin For Targeted Therapeutic Treatments
  • 23.3 Godrej Consumer Products Launches Formaldehyde-Free Botosmooth Hair Botox Treatment in Maharashtra

24 Opportunities And Strategies

  • 24.1 Global Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Neurotoxin Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Neurotoxin Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer